title: How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
abstract: Advanced age donors have inferior outcomes of liver transplantation for Hepatitis C (HCV). Aged donors grafts may be transplanted into young or low model for end stage liver disease (MELD) patients in order to offset the effect of donor age. However, it is not well understood how to utilize liver grafts from advanced aged donors for HCV patients. Using the UNOS database, we retrospectively studied 7508 HCV patients who underwent primary liver transplantation. Risk factors for graft failure and graft survival using advanced aged grafts (donor age ≥ 60 years) were analyzed by Cox hazards models, donor risk index (DRI) and organ patient index (OPI). Recipient's age did not affect on graft survival regardless of donor age. Advanced aged grafts had significant inferior survival compared to younger aged grafts regardless of MELD score (P < 0.0001). Risk factors of HCV patients receiving advanced aged grafts included donation after cardiac death (DCD, HR: 1.69) and recent hospitalization (HR: 1.43). Advanced aged grafts showed significant difference in graft survival of HCV patients with stratification of DRI and OPI. In conclusion, there was no offsetting effect by use of advanced aged grafts into younger or low MELD patients. Advanced aged grafts, especially DCD, should be judiciously used for HCV patients with low MELD score.
authors.affiliation: Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, PA 17033, USA. tuemura@hmc.psu.edu
authors.forename: Tadahiro
authors.initials: T
authors.lastname: Uemura
authors.forename: Lucas E
authors.initials: LE
authors.lastname: Nikkel
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Hollenbeak
authors.forename: Varun
authors.initials: V
authors.lastname: Ramprasad
authors.forename: Eric
authors.initials: E
authors.lastname: Schaefer
authors.forename: Zakiyah
authors.initials: Z
authors.lastname: Kadry
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D058625:End Stage Liver Disease / Q000601:surgery* / Q000821:virology; D005260:Female; D006085:Graft Survival; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D016031:Liver Transplantation / Q000208:ethnology / Q000379:methods*; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D014019:Tissue Donors; D016896:Treatment Outcome; D055815:Young Adult